Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Naltrexone Implants as Relapse Prevention

This study has been terminated.
(Recruitment difficulties. Reframed as pilot study)
Sponsor:
Information provided by:
University of Oslo
ClinicalTrials.gov Identifier:
NCT00269607
First received: December 22, 2005
Last updated: December 10, 2013
Last verified: December 2005
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2006
  Primary Completion Date: December 2006 (Final data collection date for primary outcome measure)
No publications provided by University of Oslo

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):